Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pharmacies Seek Improved Medicaid Drug Reimbursement In Reform Bill

Executive Summary

Despite favoring provisions in the Senate version of the health care reform bill that pertain to Medicaid's pharmacy reimbursement for generic drugs, the National Community Pharmacists Association is continuing to fight for a better deal

You may also be interested in...



OIG Gets Mixed Results On Question Of Medicaid Pharmacy Reimbursement

The latest analysis of Medicaid's reimbursement for multiple-source drugs finds that with an average manufacturer price-based federal upper limit, pharmacies could be reimbursed more than they paid for the drugs overall, even as a number of drugs are under-reimbursed. But retail pharmacies see the report and others like it as missing the bigger picture

OIG Gets Mixed Results On Question Of Medicaid Pharmacy Reimbursement

The latest analysis of Medicaid's reimbursement for multiple-source drugs finds that with an average manufacturer price-based federal upper limit, pharmacies could be reimbursed more than they paid for the drugs overall, even as a number of drugs are under-reimbursed. But retail pharmacies see the report and others like it as missing the bigger picture

Pharmacies Get Closer To Fixing Medicaid Drug Payments With Baucus Bill

Pharmacies have support in the Senate and House versions of health care reform legislation to change Medicaid's definition of average manufacturer price and the payment level for distribution of multiple-source drugs to Medicaid patients

Related Content

Topics

UsernamePublicRestriction

Register

PS051851

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel